Form D · Biotechnology
INTERLEUKIN GENETICS INC
Watham, MA · CIK 0001037649
Offering snapshot reported Aug 11, 2016 · SEC filing
- Reported sold
- $5.59M Offering amount: $5.59M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 29, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2016 | Initial | $5,592,500 | No comparison | 10 | SEC filing |
| Jan 8, 2015 | Initial | $5,025,000 | No comparison | 9 | SEC filing |
| May 30, 2013 | Initial | $12,000,000 | No comparison | 10 | SEC filing |
| Jul 11, 2012 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Aug 28, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-268723
Source: Form D, filed Aug 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lewis H. Bender | Director, Executive |
| Mark B. Carbeau | Director, Executive |
| Lionel Carnot | Director |
| Mary Chowning | Director |
| Roger C. Colman | Director |
| Thomas Curran | Director |
| Stephen Di Palma | Executive |
| Catherine Ehrenberger | Director |
| Goran Jurkovic | Director |
| Kenneth S. Kornman | Director, Executive |
| Joseph M. Landstra | Director |
| Eliot M. Lurier | Executive |
| William Mills | Director |
| William C. Mills Iii | Director |
| William C. Mills, Iii | Director |
| Dayton Misfeldt | Director |
| Scott Snyder | Executive |
| James Weaver | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
135 Beaver St
Watham, MA, 02452
Watham, MA, 02452